Is this your podcast?
Sign up to track ranks and reviews from iTunes, Stitcher and more
Vinay Prasad, MD MPH
Plenary Session
A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail
Listen now
Ratings & Reviews
4.9 stars from 373 ratings
Great Podcast
As a new Heme/Onc fellow, I started listening to this podcast to try and better interpret studies that I read. It’s been an educational and eye opening experience listening to Dr. Prasad. I highly recommend this for all Heme/onc fellows and residents and students who may be interested in Heme/Onc.
fnsplaya89 via Apple Podcasts · United States of America · 07/08/20
I love this podcast! I am a medical writer and work for pharma (not a favourite person!) and I love getting these insights and striving to avoid the highlighted pitfalls in my day job.
TGperson via Apple Podcasts · Great Britain · 07/07/20
Modern medicine is a business that in many areas is run for profit. The motivations of business lead to all sorts of biases and statistical machinations to bring new therapies to the (broken) market. Dr Prasad knows all of these tricks and dissects them thoroughly. He is unabashed and a...Read full review »
brighton punter via Apple Podcasts · Great Britain · 06/26/20
Recent Episodes
This week we discuss recent research (and the accompanying Twitter thread) on the risk of COVID-19 among users of proton pump inhibitors (PPIs). We also hold a philosophical discussion on the research surrounding time to treatment initiation (TTI) in cancer medicine. We end the episode with an...
Published 07/11/20
This BONUS episode is the recording of a lecture given on June 18, 2020 as part of Stanford's METRICS International Forum. METRICS stands for Meta-Research Innovation Center at Stanford University. This lecture is geared towards a broad audience and aims to provide a general sense of current...
Published 07/07/20
This week we respond to some listener feedback from Dr. Christopher Booth and use it to talk about how to be the best hematologist-oncologist. We also discuss the SADAL study on Selinexor for patients with relapsed refractory diffuse large B-cell lymphoma, as published in The Lancet...
Published 07/03/20
Do you host a podcast?
Track your ranks and reviews from iTunes, Stitcher and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »